| CELU Stock | | | USD 2.76 0.09 3.16% |
VP
MBA MD is Chief VP of Celularity
| Age | 53 |
| Address | 170 Park Avenue, Florham Park, NJ, United States, 07932 |
| Phone | 908 768 2170 |
| Web | https://www.celularity.com |
Celularity Management Efficiency
The company has return on total asset
(ROA) of
(0.1463) % which means that it has lost $0.1463 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(1.5423) %, meaning that it created substantial loss on money invested by shareholders. Celularity's management efficiency ratios could be used to measure how well Celularity manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to gain to -1.49 in 2024.
Return On Capital Employed is likely to gain to -2.39 in 2024.
Total Current Liabilities is likely to gain to about 70.7
M in 2024, whereas
Liabilities And Stockholders Equity is likely to drop slightly above 338.4
M in 2024.
Celularity currently holds 39.24
M in liabilities with Debt to Equity
(D/E) ratio of 0.41, which is about average as compared to similar companies. Celularity has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Celularity's use of debt, we should always consider it together with its cash and equity.
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey. Celularity operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people. Celularity (CELU) is traded on NASDAQ Exchange in USA. It is located in 170 Park Avenue, Florham Park, NJ, United States, 07932 and employs 120 people. Celularity is listed under Biotechnology category by Fama And French industry classification.
Management Performance
Celularity Leadership Team
Elected by the shareholders, the Celularity's board of directors comprises two types of representatives: Celularity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Celularity. The board's role is to monitor Celularity's management team and ensure that shareholders' interests are well served. Celularity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Celularity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Carlos Ramirez, SVP Relations | |
| Sharmila MD, Senior Safety | |
| CFA CFA, Chief Officer | |
| Tim Wilk, Senior Operations | |
| Ramji Krishnan, Chief Officer | |
| Bradley Glover, Ex COO | |
| CPA MS, Treasurer | |
| Stephen DPM, President Diseases | |
| David CFA, Chief Officer | |
| MBA MD, Chief VP | |
| John Haines, Global EVP | |
| Robert MD, CEO Founder | |
| Beth Steinbrenner, Ex HR | |
| Timothy Smith, Secretary | |
| Keary Esq, Gen EVP | |
| Anne Jones, Exec Officer | |
| Kyle Esq, General VP | |
Celularity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Celularity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to
measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to
predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.